[Curative treatment of Dühring-Brocq disease using BCG vaccination (part 2)].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D003874:Dermatitis Herpetiformis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000628:therapy; D012867:Skin / Q000473:pathology; D013223:Statistics as Topic; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000276:immunology
D000305:Adrenal Cortex Hormones; D001500:BCG Vaccine
Traitement curatif de la maladie de Dühring-Brocq par la vaccination BCG (seconde partie)